Emel Serap Monkul Nery

Statistics

Publications

Citations

2.8K

H-Index

Active since

2016

Affiliations

Eli Lilly (United States)(Current)

Butler Hospital

Brown University

Providence College

Indiana University School of Medicine

Emel Serap Monkul Nery is an author at Eli Lilly (United States) specializing in dementia treatment, neurodegeneration, and neurodegenerative diseases.

Publications per year

2016–2025

Publications

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease

Jennifer A. Zimmer, Paul Ardayfio, Hong Wang et al. · JAMA Neurology · 2025 · 117 citations · Full text

Medicine, Neurology, Neuroscience +17

Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction

Hong Wang, Emel Serap Monkul Nery, Paul Ardayfio et al. · Alzheimer s & Dementia · 2025 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine

Max Tsai, Emel Serap Monkul Nery, Lisa Kerr et al. · Clinical Pharmacokinetics · 2021 · 18 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies

Timothy R. Smith, John H. Krege, Suchitrita S. Rathmann et al. · Neurology and Therapy · 2020 · 13 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +14

1–5 of 9